SeaStar Medical Holding Free Cash Flow 2021-2024 | ICU
SeaStar Medical Holding free cash flow from 2021 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| SeaStar Medical Holding Annual Free Cash Flow | |
|---|---|
| 2023 | -10.29 |
| 2022 | -7.79 |
| 2021 | -5.11 |
| 2020 | -0.11 |
| SeaStar Medical Holding Quarterly Free Cash Flow | |
|---|---|
| 2024-06-30 | -6.31 |
| 2024-03-31 | -3.49 |
| 2023-12-31 | -10.29 |
| 2023-09-30 | -5.80 |
| 2023-06-30 | -4.46 |
| 2023-03-31 | -2.29 |
| 2022-12-31 | -7.79 |
| 2022-09-30 | -2.49 |
| 2022-06-30 | -1.58 |
| 2022-03-31 | -0.59 |
| 2021-12-31 | -5.11 |
| 2021-09-30 | -0.37 |
| 2021-06-30 | -0.32 |
| 2021-03-31 | -0.28 |
| 2020-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.013B | $0.000B |
| SeaStar Medical Holding Corporation is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. SeaStar Medical Holding Corporation, formerly known as LMF Acquisition Opportunities Inc., is based in Denver, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $96.018B | 11.91 |
| Cencora (COR) | United States | $46.162B | 17.64 |
| DiDi Global (DIDIY) | China | $23.816B | 0.00 |
| ICON (ICLR) | Ireland | $18.182B | 16.19 |
| Natera (NTRA) | United States | $15.356B | 0.00 |
| Avantor (AVTR) | United States | $15.184B | 22.76 |
| Revvity (RVTY) | United States | $14.929B | 26.14 |
| Viatris (VTRS) | United States | $13.870B | 4.23 |
| BioMerieux (BMXMF) | France | $12.753B | 0.00 |
| Solventum (SOLV) | United States | $12.515B | 0.00 |
| CochLear (CHEOY) | Australia | $12.315B | 0.00 |
| Medpace Holdings (MEDP) | United States | $9.932B | 27.98 |
| Charles River Laboratories (CRL) | United States | $9.343B | 17.66 |
| Sonic Healthcare (SKHHY) | Australia | $8.376B | 0.00 |
| Doximity (DOCS) | United States | $7.863B | 49.82 |
| HealthEquity (HQY) | United States | $7.539B | 40.92 |
| Bausch + Lomb (BLCO) | Canada | $7.221B | 33.62 |
| PACS (PACS) | United States | $6.544B | 0.00 |
| Life Times (LTH) | United States | $4.665B | 30.88 |
| Organon (OGN) | United States | $4.653B | 4.69 |
| Sotera Health (SHC) | United States | $4.492B | 22.66 |
| Surgery Partners (SGRY) | United States | $3.655B | 40.49 |
| BrightSpring Health Services (BTSG) | United States | $2.958B | 63.89 |
| Concentras Parent (CON) | United States | $2.542B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.527B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.482B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.349B | 88.43 |
| GeneDx Holdings (WGS) | United States | $2.094B | 0.00 |
| Premier (PINC) | United States | $2.032B | 9.14 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.922B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.586B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.402B | 7.04 |
| Progyny (PGNY) | United States | $1.354B | 23.81 |
| Pediatrix Medical (MD) | United States | $1.306B | 12.78 |
| Establishment Labs Holdings (ESTA) | $1.269B | 0.00 | |
| CareDx (CDNA) | United States | $1.194B | 0.00 |
| Agilon Health (AGL) | United States | $1.111B | 0.00 |
| Embecta (EMBC) | United States | $0.822B | 5.48 |
| InnovAge Holding (INNV) | United States | $0.803B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 0.00 |
| SBC Medicals (SBC) | United States | $0.707B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.505B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.470B | 0.00 |
| DocGo (DCGO) | United States | $0.371B | 13.96 |
| Enhabit (EHAB) | United States | $0.365B | 31.52 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.325B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.261B | 0.00 |
| ModivCare (MODV) | United States | $0.230B | 7.32 |
| Beauty Health (SKIN) | United States | $0.206B | 0.00 |
| Biodesix (BDSX) | United States | $0.189B | 0.00 |
| LifeMD (LFMD) | United States | $0.186B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.184B | 0.00 |
| MultiPlan (MPLN) | United States | $0.148B | 0.00 |
| Nutex Health (NUTX) | United States | $0.114B | 0.00 |
| So-Young (SY) | China | $0.089B | 21.53 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.059B | 0.00 |
| OncoCyte (OCX) | United States | $0.051B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.69 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.037B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.034B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.025B | 0.00 |
| Oncology Institute (TOI) | United States | $0.023B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| KindlyMD (KDLY) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |